Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy

QR Code

Expansion of adaptive NK cells in HIV disease persists following combination antiretroviral therapy

Bibliographic Details
Main Authors:	Hearps, A., Zhou, J., Brunt, S., Agius, P., Price, Patricia, Elliott, J., Jaworowski, A.
Format:	Conference Paper
Published:	WILEY-BLACKWELL 2016
Online Access:	http://hdl.handle.net/20.500.11937/30928

Similar Items

Persistence of Activated and Adaptive-Like NK Cells in HIV+ Individuals despite 2 Years of Suppressive Combination Antiretroviral Therapy
by: Hearps, A., et al.
Published: (2017)

An NK cell population lacking FcR? is expanded in chronically infected HIV patient
by: Zhou, J., et al.
Published: (2015)

The high frequency of autoantibodies in HIV patients declines on antiretroviral therapy
by: Bundell, C., et al.
Published: (2018)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Do Cytomegalovirus Antibody Levels Associate with Age-Related Syndromes in HIV Patients Stable on Antiretroviral Therapy?
by: Brunt, S., et al.
Published: (2016)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

The dynamics of HCV-specific antibody responses in HIV/HCV patients on long-term antiretroviral therapy
by: Lee, S., et al.
Published: (2017)

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

IL1A alleles associate with a virological response to antiretroviral therapy in HIV patients beginning therapy with advanced disease
by: Price, Patricia, et al.
Published: (2009)

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.
by: Oliver, B., et al.
Published: (2012)

Immunological and epidemiological factors affecting candidiasis in HIV patients beginning antiretroviral therapy in an Asian clinic
by: Wulandari, E., et al.
Published: (2017)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Could natural killer cells compensate for impaired CD4+ T-cell responses to CMV in HIV patients responding to antiretroviral therapy?
by: Tan, D., et al.
Published: (2009)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

CD4+ and CD8+ T cells expressing FoxP3 in HIV-infected patients are phenotypically distinct and influenced by disease severity and antiretroviral therapy
by: Lim, A., et al.
Published: (2009)

The number and function of circulating dendritic cells may limit effector memory CD4+ T-cell responses in HIV patients responding to antiretroviral therapy
by: Fernandez, S., et al.
Published: (2008)

Polymorphisms in IL10 may alter CD4 T-cell counts in Indonesian HIV patients beginning antiretroviral therapy
by: Dmello, D., et al.
Published: (2017)

The role of human herpesvirus (HHV) infections and persistent immune activation in antiretroviral therapy-treated HIV infected individuals / Yap Siew Hwei
by: Yap, Siew Hwei
Published: (2018)

CMV drives the expansion of highly functional memory T cells expressing NK-cell receptors in renal transplant recipients
by: Makwana, N., et al.
Published: (2017)

Immunopathogenesis of hepatic flare in HIV/hepatitis b virus (Hbv)-coinfected individuals after the initiation of Hbv-active antiretroviral therapy
by: Crane, M., et al.
Published: (2009)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

The Use of Humoral Responses as a Marker of CMV Burden in HIV Patients on ART Requires Consideration of T-Cell Recovery and Persistent B-Cell Activation
by: Brunt, S., et al.
Published: (2014)

CD4 + T-cell deficiency in HIV patients responding to antiretroviral therapy is associated with increased expression of interferon-stimulated genes in CD4 + T cells
by: Fernandez, S., et al.
Published: (2011)

Kepatuhan pesakit HIV positif terhadap rawatan Highly Active Antiretroviral Therapy (HAART)
by: Najwa Afiqa Roshaizad,, et al.
Published: (2020)

Factors associated with abdominal obesity among HIV-infected adults on antiretroviral therapy in Malaysia
by: Hejazi, Nazisa, et al.
Published: (2010)

HIV-negative and HIV-positive gay men's attitudes to medicines, HIV treatments and antiretroviral-based prevention
by: Holt, M., et al.
Published: (2013)

Graves’ thyrotoxicosis as a manifestation Of immune reconstitution inflammatory syndrome in HIV patients on antiretroviral therapy
by: Goh, Kian Guan, et al.
Published: (2017)

Hypertension among HIV-infected adults receiving highly active antiretroviral therapy (HAART) in Malaysia
by: Hejazi, Nazisa, et al.
Published: (2014)

Predictors of adherence behaviour among HIV positive patients receiving Antiretroviral Therapy (ART) in Malaysia
by: Abdulrahman, Surajudeen Abiola, et al.
Published: (2015)

The immunological footprint of CMV in HIV-1 patients stable on long-term ART
by: Affandi, J., et al.
Published: (2015)

Socioeconomic predictors of adherence behavior among HIV-positive patients receiving antiretroviral therapy in Selangor, Malaysia
by: Abdulrahman, Surajudeen Abiola, et al.
Published: (2017)

Adherence to Antiretroviral Therapy and Virologic Failure
by: Bezabhe, W., et al.
Published: (2016)

Increased proportion of the CD56bright NK cell subset in patients chronically infected with Hepatitis C Virus (HCV) receiving interferon-a and ribavirin therapy
by: Lee, S., et al.
Published: (2010)

Use of antiretroviral treatment among people living with HIV in Australia between 1997 and 2012
by: Power, J., et al.
Published: (2017)

Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes - a randomised controlled trial protocol
by: Parry, C.D.H., et al.
Published: (2014)

Quality of life of people living with HIV/AIDS (PLWHIV) Receiving Antiretroviral Therapy (ART) / Rahayu Abd.Manan
by: Abd.Manan, Rahayu
Published: (2016)

Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: A study protocol
by: Bezabhe, W., et al.
Published: (2013)

Ethnicity as predictor of immune reconstitution among Malaysian HIV‐positive patients treated with highly active antiretroviral therapy
by: Mohamad Isa, Irma Izani, et al.
Published: (2020)

The effect of genetic variants affecting NK cell function on cardiovascular health and the burden of CMV
by: Waters, Shelley, et al.
Published: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ge8a17d5pc3fape9kek1nh8q2s